D. E. Shaw & Co., Inc. Kamada LTD Transaction History
D. E. Shaw & Co., Inc.
- $125 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding KMDA
# of Institutions
44Shares Held
5.82MCall Options Held
21KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$11.7 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny872KShares$6.16 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA606KShares$4.29 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA396KShares$2.8 Million0.48% of portfolio
-
Acadian Asset Management LLC Boston, MA274KShares$1.94 Million0.0% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $317M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...